TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
Clinical trials for TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) explained in plain language.
Never miss a new study
Get alerted when new TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) trials appear
Sign up with your email to follow new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common blood pressure pill protect the heart after valve replacement?
Disease control Not yet recruitingThis trial tests whether angiotensin receptor blockers (ARBs), a type of blood pressure medication, can reduce the risk of death or heart failure in people who have had a transcatheter aortic valve replacement (TAVR) for severe aortic stenosis and still have a thickened heart mus…
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
No X-Rays, no dye: new heart valve procedure could protect kidneys
Disease control Not yet recruitingThis study tests a new way to replace a leaky heart valve (aortic regurgitation) without using X-rays or contrast dye, which can harm the kidneys. Instead, doctors will use only ultrasound (echocardiography) to guide the procedure. The goal is to see if this approach is safe and …
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study to uncover why strokes strike after heart treatments
Knowledge-focused Not yet recruitingThis study will observe 400 adults who have a stroke within 28 days of a heart procedure, such as a stent or valve replacement. The goal is to learn more about these strokes, including how severe they are and how well current treatments work. No new drugs or devices are being tes…
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
Sponsor: University of L'Aquila • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC